United States Biotechnology & Medical Research

Mural Oncology PLC (MURA)

Track

Ticker: MURA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 10 Nov 2025
Value US$4,913,941.45 | Price 317.61 | Shares 35,916
Planned sale 10 Nov 2025
Value US$1,252,243.82 | Price 470.91 | Shares 54,217 (-16.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-10 2025-11-10 PrS Proposed sale
Goodman Vicki L

Officer

Officer
35,916
317.61
US$4,913,941 		35,916 317.61 US$4,913,941
2025-11-10 2025-11-10 PlS Planned sale
Goodman Vicki L

Chief Medical Officer

Officer
54,217 -16.0%
470.91
US$1,252,244 		54,217 -16.0% 470.91 US$1,252,244
2025-11-10 2025-11-03 PrS Proposed sale
Cutler Adam D.

Officer

Officer
74,676
73.09
US$3,932,174 		74,676 73.09 US$3,932,174
2025-11-10 2025-11-03 PlS Planned sale
Cutler Adam D.

Chief Financial Officer

Officer
7,148 -6.7%
2.09
US$14,939 		7,148 -6.7% 2.09 US$14,939
2025-07-23 2025-07-22 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,572 -3.6%
2.48
US$6,379 		2,572 -3.6% 2.48 US$6,379
2025-07-22 2025-07-22 PrS Proposed sale
Maiken Keson-Brookes

CLO
2,572
2.49
US$6,404 		2,572 2.49 US$6,404
2025-07-22 2025-07-18 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,158 -2.9%
2.48
US$5,352 		2,158 -2.9% 2.48 US$5,352
2025-07-09 2025-07-07 PrS Proposed sale
Loew Caroline

Officer; Director

Executive Director
12,513
2.43
US$30,469 		12,513 2.43 US$30,469
2025-07-09 2025-07-07 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
12,531 -4.1%
2.43
US$30,475 		12,531 -4.1% 2.43 US$30,475
2025-03-05 2025-03-05 PrS Proposed sale
Maiken Keson-Brookes

CLO
1,469
3.43
US$5,039 		1,469 3.43 US$5,039
2025-03-05 2025-03-05 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
1,469 -2.0%
3.45
US$5,068 		1,469 -2.0% 3.45 US$5,068
2025-03-05 2025-03-04 PrS Proposed sale
Loew Caroline

Officer; Director

Executive Director
4,313
3.36
US$14,491 		4,313 3.36 US$14,491
2025-03-05 2025-03-04 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
1,262 -1.7%
3.36
US$4,240 		1,262 -1.7% 3.36 US$4,240
2025-03-05 2025-03-04 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
4,313 -1.4%
3.36
US$14,492 		4,313 -1.4% 3.36 US$14,492
2025-02-25 2025-02-24 PlS Planned sale
Goodman Vicki L

Chief Medical Officer

Officer
13,186 -19.4%
3.89
US$51,294 		13,186 -19.4% 3.89 US$51,294
2025-02-24 2025-02-24 PrS Proposed sale
Vicki Goodman

Officer

Officer
13,186
4.04
US$53,271 		13,186 4.04 US$53,271
2024-12-26 2024-12-23 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,555 -5.8%
3.27
US$8,355 		2,555 -5.8% 3.27 US$8,355
2024-12-23 2024-12-23 PrS Proposed sale
Maiken Keson-Brookes

CLO
2,555
3.25
US$8,304 		2,555 3.25 US$8,304
2024-12-18 2024-12-17 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
2,763 -1.1%
3.40
US$9,394 		2,763 -1.1% 3.40 US$9,394
2024-11-08 2024-11-07 PrS Proposed sale
Goodman Vicki L

Officer

Officer
5,069
3.33
US$16,870 		5,069 3.33 US$16,870
2024-11-08 2024-11-07 PlS Planned sale
Goodman Vicki L

Chief Medical Officer

Officer
5,069 -6.9%
3.33
US$16,880 		5,069 -6.9% 3.33 US$16,880
2024-11-01 2024-10-31 PrS Proposed sale
Cutler Adam D.

Officer

Officer
7,421
3.41
US$25,306 		7,421 3.41 US$25,306
2024-11-01 2024-10-31 PlS Planned sale
Cutler Adam D.

Chief Financial Officer

Officer
7,421 -9.4%
3.41
US$25,306 		7,421 -9.4% 3.41 US$25,306
2024-08-15 2024-08-14 B Purchase
1.9
ALTSCHULLER Susan
Non-Executive Director
10,000 +inf%
3.21
US$32,071 		10,000 +inf% 3.21 US$32,071
2024-07-18 2024-07-18 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,157 -4.7%
3.41
US$7,355 		2,157 -4.7% 3.41 US$7,355
2024-07-08 2024-07-08 PrS Proposed sale
Loew Caroline

Officer; Director

Executive Director
12,531
2.91
US$36,469 		12,531 2.91 US$36,469
2024-07-08 2024-07-08 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
12,531 -5.0%
2.91
US$36,465 		12,531 -5.0% 2.91 US$36,465
Explore more

More insider trading research around Mural Oncology PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America